Dimensional Fund Advisors’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.26M | Sell |
714,866
-12,964
| -2% | -$132K | ﹤0.01% | 2407 |
|
|
2025
Q1 | $4.06M | Buy |
727,830
+10,642
| +1% | +$59.4K | ﹤0.01% | 2555 |
|
|
2024
Q4 | $5.79M | Buy |
717,188
+103,237
| +17% | +$833K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $6.29M | Buy |
613,951
+147,289
| +32% | +$1.51M | ﹤0.01% | 2454 |
|
|
2024
Q2 | $3.3M | Buy |
466,662
+305,860
| +190% | +$2.16M | ﹤0.01% | 2620 |
|
|
2024
Q1 | $2.21M | Buy |
160,802
+136,126
| +552% | +$1.87M | ﹤0.01% | 2771 |
|
|
2023
Q4 | $227K | Sell |
24,676
-16
| -0.1% | -$147 | ﹤0.01% | 3178 |
|
|
2023
Q3 | $149K | Buy |
24,692
+16
| +0.1% | +$97 | ﹤0.01% | 3259 |
|
|
2023
Q2 | $191K | Buy |
24,676
+14,632
| +146% | +$114K | ﹤0.01% | 3243 |
|
|
2023
Q1 | $57.3K | Buy |
+10,044
| New | +$57.3K | ﹤0.01% | 3372 |
|